Global Polycythemia Vera Drug Market Data Survey Report 2025
- HEY2811286
- 70 Pages
- November 2018
- Medical Devices
The global Polycythemia Vera Drug market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
ANP Technologies, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Galena Biopharma, Inc.
Gilead Sciences, Inc.
Italfarmaco S.p.A.
Italfarmaco S.p.A.
miRagen Therapeutics, Inc.
Nerviano Medical Sciences S.r.l.
Novartis AG
PharmaEssentia Corporation
Teva Pharmaceutical Industries Ltd.
Major applications as follows:
Clinic
Hospital
Others
Major Type as follows:
Dasatinib
Idelalisib
Givinostat
M-009
Others
Regional market size, production data and Trade:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 ANP Technologies, Inc.
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Bristol-Myers Squibb Company
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 F. Hoffmann-La Roche Ltd.
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Galena Biopharma, Inc.
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Gilead Sciences, Inc.
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Italfarmaco S.p.A.
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Italfarmaco S.p.A.
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 miRagen Therapeutics, Inc.
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Nerviano Medical Sciences S.r.l.
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Novartis AG
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 PharmaEssentia Corporation
3.12 Teva Pharmaceutical Industries Ltd.
4 Major Application
4.1 Clinic
4.1.1 Overview
4.1.2 Clinic Market Size and Forecast
4.2 Hospital
4.2.1 Overview
4.2.2 Hospital Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 Market by Type
5.1 Dasatinib
5.1.1 Overview
5.1.2 Dasatinib Market Size and Forecast
5.2 Idelalisib
5.2.1 Overview
5.2.2 Idelalisib Market Size and Forecast
5.3 Givinostat
5.3.1 Overview
5.3.2 Givinostat Market Size and Forecast
5.4 M-009
5.4.1 Overview
5.4.2 M-009 Market Size and Forecast
5.5 Others
5.5.1 Overview
5.5.2 Others Market Size and Forecast
5.6 Others
5.6.1 Overview
5.6.2 Others Market Size and Forecast
6 Conclusion
Tab Regional Production 2012-2017 (Volume)
Tab Regional Demand and CAGR 2012-2017 (Million USD)
Tab Regional Demand and CAGR 2012-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of ANP Technologies, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Company
Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of Galena Biopharma, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead Sciences, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Italfarmaco S.p.A.
Tab Sales Revenue, Volume, Price, Cost and Margin of Italfarmaco S.p.A.
Tab Sales Revenue, Volume, Price, Cost and Margin of miRagen Therapeutics, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Nerviano Medical Sciences S.r.l.
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Tab Sales Revenue, Volume, Price, Cost and Margin of PharmaEssentia Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd.
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
